|
|
Volumn 69, Issue 15, 2007, Pages 1555-
|
|
Neutralizing antibodies to interferon beta: Assessment of their clinical and radiographic impact: An evidence report: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology [5]
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA INTERFERON;
INTERFERON ANTIBODY;
INTERFERON RECEPTOR;
NEUTRALIZING ANTIBODY;
ANTIBODY;
ANTIBODY DETECTION;
ANTIBODY TITER;
DRUG ACTIVITY;
DRUG EFFECT;
DRUG RECEPTOR BINDING;
DRUG WITHDRAWAL;
GENE CONTROL;
HUMAN;
LETTER;
MULTIPLE SCLEROSIS;
PRIORITY JOURNAL;
RECURRENT DISEASE;
TREATMENT DURATION;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
UPREGULATION;
BIOASSAY;
DRUG ANTAGONISM;
DRUG RESISTANCE;
EVIDENCE BASED MEDICINE;
GENE EXPRESSION REGULATION;
IMMUNOLOGY;
METABOLISM;
NOTE;
PRACTICE GUIDELINE;
STANDARD;
TREATMENT FAILURE;
ANTIBODIES;
BIOLOGICAL ASSAY;
DRUG RESISTANCE;
EVIDENCE-BASED MEDICINE;
GENE EXPRESSION REGULATION;
HUMANS;
INTERFERON-BETA;
MULTIPLE SCLEROSIS;
PRACTICE GUIDELINES AS TOPIC;
TREATMENT FAILURE;
|
|
EID: 35148849745
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/01.wnl.0000295672.17358.95 Document Type: Letter |
|
Times cited : (3)
|
|
References (0)
|
